The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy

Charles C. Peyton, E. Jason Abel, Juan Chipollini, David C. Boulware, Mounsif Azizi, Jose A. Karam, Vitaly Margulis, Viraj A. Master, Surena F. Matin, Jay D. Raman, Wade J. Sexton, Christopher G. Wood, Philippe E. Spiess

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

We identified the neutrophil-lymphocyte ratio and six additional preoperative variables as predictive of worse survival specific to patients with metastatic renal cell carcinoma (mRCC) and tumor thrombus undergoing cytoreductive nephrectomy. The predictive model outperformed established risk predictors of mRCC.

Original languageEnglish (US)
Pages (from-to)104-111
Number of pages8
JournalEuropean Urology Focus
Volume6
Issue number1
DOIs
StatePublished - Jan 15 2020

Keywords

  • Carcinoma
  • Mortality
  • Neoplasm metastasis
  • Renal cell
  • Survival
  • Thrombosis

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy'. Together they form a unique fingerprint.

  • Cite this

    Peyton, C. C., Abel, E. J., Chipollini, J., Boulware, D. C., Azizi, M., Karam, J. A., Margulis, V., Master, V. A., Matin, S. F., Raman, J. D., Sexton, W. J., Wood, C. G., & Spiess, P. E. (2020). The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy. European Urology Focus, 6(1), 104-111. https://doi.org/10.1016/j.euf.2018.08.023